XENiOS® Will Seek Regulatory Approval for i-lung®

XENiOS®, a commercial-stage medical device company, announced today it expects to receive CE-marking for its i-lung® device within 18 months. XENIOS expects to launch i-lung® in 2017. Currently available devices lack durability and wearability. Additionally, the size of current systems restricts patient mobility and limits quality of life. i-lung represents an innovative and first-of-its-kind fully wearable artificial lung for long-term use in a hospital environment.

"The availability of i-lung will open the door to significant medical progress for respiratory support. For many patients in lung failure currently undergoing invasive mechanical ventilation, the use of i-lung is designed to avoid sedation and immobility, thus creating active, self-managed patients," said Georg Matheis, MD, Managing Director & Founder of XENIOS. "In addition, i-lung is designed to be used to bridge the waiting time for a donor organ (bridge-to-lung-transplant)."

"Of special note," added Juergen Boehm, MD, Managing Director of Xenios, "i-lung paves the way for XENiOS to continue development of a bioartificial lung for use by patients outside of a hospital environment analogous to current artificial heart protocols, which will represent a paradigm shift in the approach to long-term respiratory support."

i-lung is the result of the successful completion of the AmbuLung project, a three-year R&D consortium project funded by the European Union’s FP7 Program that developed the basis for i-lung, the world’s first-of-its-kind wearable artificial lung. In addition to XENiOS, the consortium included Fraunhofer IGB (Stuttgart, Germany); Imperial College of Science, Technology and Medicine (London, UK); and, the University of Florence (Italy).

"We are forever indebted to the vision and the work of Professor Dame Julia Polak, who passed away last year," said Dr. Matheis. "Julia and I co-founded the i-lung project, and because of her enormous contribution i-lung is now a reality, and a bioartificial next-gen of i-lung on the horizon." The author of some 1,000 original papers, 115 review articles and editor or author of 25 books, Julia Polak, MD, PhD, was one of the most widely cited researchers in her field, and had undergone a heart lung transplant. She served on several national and international tissue engineering and stem cell advisory panels, and was the European editor of the journal Tissue Engineering.

Funding for the commercialization of i-LUNG® has already been procured. XENIOS announced in September 2015 that it received an eight-figures cash infusion from existing investors, in part to fund CE-marking and launch of i-LUNG, led by ZFHN, one of the largest Single Family Offices in Germany investing in start-up companies.

About XENiOS®
XENiOS AG is a privately held medical technology company that is comprised of two product brands, novalung® and i–cor®, that run on a single XENiOS® console. The XENIOS platform is designed to provide at least four essential advantages with its minimally invasive lung and heart therapies: (1) patients are awake and mobile;(2) self-actuated patients facilitate improved outcomes; (3) there is no ventilator-associated lung injury or pneumonia; (4) additionally, the XENIOS platform maintains a physiologic natural pulse designed to protect the heart.

Most Popular Now

SAP IoT Startup Accelerator

The SAP IoT Startup Accelerator is a structured co-innovation program for selected B2B startups focusing on the Internet of Things. The Accelerator helps startups grow and scale their businesses alongside...

Read more

Paving the Way for eHealth Interoperabil…

The EURO-CAS project launched operations today to deliver the eHealth Conformity Assessment Scheme for Europe in 2018. This scheme will help European health systems assess the conformity of eHealth products...

Read more

SkinVision Unveils Breakthrough Algorith…

Dutch mobile health startup SkinVision has revealed its new algorithm that can detect most common forms of deadly skin cancer. Previously focused on detecting melanoma skin cancer, the app can...

Read more

eHealth Hub Solution Match Call: Hospita…

Solution Match is one of the services offered by the EU-funded initiative eHealth Hub, intending to promote and boost up commercialization. The eHealth Hub aims to provide long-term support to...

Read more

Wearable AI System can Detect a Conversa…

It's a fact of nature that a single conversation can be interpreted in very different ways. For people with anxiety or conditions such as Asperger's, this can make social situations...

Read more

Biovision World Life Science Forum 2017

4 - 6 April 2017, Lyon, France. Biovision World Life Science Forum is fostering a unique approach to meet, connect and collaborate between international decision-makers from the academic, civil society, policy-making...

Read more

Doctrina Raises €1,020,000 of New Capita…

Doctrina, a start-up company transforming the traditional transfer of knowledge between pharmaceutical companies and pharmacies, has raised a total of €1,020,000 in series A funding. The investment will enable Doctrina...

Read more

DIY Live Cell Imaging Using a Smartphone

A recent study from Uppsala University shows how smartphones can be used to make movies of living cells, without the need for expensive equipment. The study is published in the...

Read more

Horder Healthcare Uses IMS MAXIMS Electr…

Healthcare provider Horder Healthcare is to deploy an electronic patient record (EPR) from software provider IMS MAXIMS, in order to improve care for thousands of patients and facilitate its digital...

Read more

Brain-Computer Interface Allows Complete…

A brain-computer interface that can decipher the thoughts of people who are unable to communicate could revolutionize the lives of those living with complete locked-in syndrome according to a new...

Read more

Pitch Your Digital Health Solution at th…

The second eHealth Roadshow, promoted by the new EU-funded eHealth Hub project, will take place on the 6th of April in Stuttgart, Germany, in the frame of the Medtec Europe...

Read more

Deep Learning in Healthcare Summit

28 - 01 March 2017, London, UK. Discover advances in deep learning tools and techniques from the world's leading innovators across industry, academia and the healthcare sector. Learn from the experts...

Read more
(HEALTH IT) SPACE - Take a look at who has just Joined